Thema
Antibodies, Monoclonal, Humanized
55.255
Journal Article
46.033
Antibodies, Monoclonal
23.452
Research Support, Non-U.S. Gov't
16.714
Review
9.837
Case Reports
8.690
Bevacizumab
8.118
2S9ZZM9Q9V
8.105
Antineoplastic Agents
7.957
EC 2.7.10.1
6.993
Letter
6.338
Angiogenesis Inhibitors
6.308
Trastuzumab
5.362
P188ANX8CK
5.349
Randomized Controlled Trial
4.958
Multicenter Study
4.830
Vascular Endothelial Growth Factor A
4.026
pembrolizumab
3.923
DPT0O3T46P
3.901
Receptor, ErbB-2
3.834
Comment
3.813
Adalimumab
3.578
FYS6T7F842
3.561
tocilizumab
3.255
I031V2H011
3.244
Research Support, N.I.H., Extramural
3.209
Cetuximab
3.185
PQX0D8J21J
3.170
Comparative Study
2.924
Clinical Trial, Phase II
2.867
Antirheumatic Agents
2.822
Immunosuppressive Agents
2.786
Tumor Necrosis Factor-alpha
2.778
Immunoglobulin G
2.526
ErbB Receptors
2.334
Antineoplastic Agents, Immunological
2.160
Infliximab
2.050
B72HH48FLU
2.033
Clinical Trial, Phase III
2.015
Ranibizumab
1.920
ZL1R02VT79
1.918
Alemtuzumab
1.772
3A189DH42V
1.770
VEGFA protein, human
1.674
Klinische Studie
1.639
ERBB2 protein, human
1.609
Clinical Trial, Phase I
1.565
Anti-Inflammatory Agents
1.552
Fluorouracil
1.528
U3P01618RT
1.528
mehr ...